These results reveal that ILT4 functions as a tumor enhancer in NSCLC that promotes tumor growth and metastasis, at least partly, through activation of ERK signaling and upregulation of VEGF-C expression. This evidence concerns the gene LILRB2 and non-small cell lung carcinoma.